FDA Addresses the Use of CBD as an Inactive Ingredient in Two Warning Letters to Companies Selling Topical OTC Drug Products with CBD
While the Food and Drug Administration (“FDA”) has issued numerous warning letters to companies marketing cosmetic, food, dietary supplement, and other consumer … more